Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Green Med Solution (BGMS) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Bio Green Med Solution (BGMS) over the last 17 years, with Q3 2025 value amounting to $1.9 million.

  • Bio Green Med Solution's Shares Outstanding (Weighted Average) rose 418033.17% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 418033.17%. This contributed to the annual value of $9.9 million for FY2022, which is 1050.98% up from last year.
  • Bio Green Med Solution's Shares Outstanding (Weighted Average) amounted to $1.9 million in Q3 2025, which was up 418033.17% from $44681.0 recorded in Q3 2024.
  • In the past 5 years, Bio Green Med Solution's Shares Outstanding (Weighted Average) registered a high of $11.9 million during Q3 2023, and its lowest value of $44681.0 during Q3 2024.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $9.4 million (2023), whereas its average is $8.3 million.
  • Per our database at Business Quant, Bio Green Med Solution's Shares Outstanding (Weighted Average) tumbled by 9962.46% in 2024 and then surged by 418033.17% in 2025.
  • Over the past 5 years, Bio Green Med Solution's Shares Outstanding (Weighted Average) (Quarter) stood at $8.9 million in 2021, then rose by 10.51% to $9.9 million in 2022, then rose by 20.66% to $11.9 million in 2023, then tumbled by 99.62% to $44681.0 in 2024, then skyrocketed by 4180.33% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, $44681.0 for Q3 2024, and $11.9 million during Q3 2023.